BDNF and Cognitive impairment: Furthermore, Geraghty et al. demonstrated that loss of adaptive myelination contributes to MTX chemotherapy-related cognitive impairment through the evidence that microglial-dependent reduction of BDNF expression and loss of activity-regulated myelination [32].